531 related articles for article (PubMed ID: 16449999)
21. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
23. Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray.
Bernasconi M; Berger C; Sigrist JA; Bonanomi A; Sobek J; Niggli FK; Nadal D
Virol J; 2006 Jun; 3():43. PubMed ID: 16756670
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas.
Kanavaros P; Briere J; Emile JF; Gaulard P
Leukemia; 1996 Jun; 10 Suppl 2():s84-7. PubMed ID: 8649060
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
26. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
27. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
28. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
[TBL] [Abstract][Full Text] [Related]
29. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
[TBL] [Abstract][Full Text] [Related]
30. Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.
Libra M; Gloghini A; De Re V; Rupolo M; Navolanic PM; Gasparotto D; Stivala F; Spina M; Boiocchi M; Carbone A
Int J Oncol; 2005 Apr; 26(4):945-50. PubMed ID: 15753988
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
[TBL] [Abstract][Full Text] [Related]
32. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
34. Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.
Nagata H; Numata T; Konno A; Mikata I; Kurasawa K; Hara S; Nishimura M; Yamamoto K; Shimizu N
Pathol Int; 2001 Oct; 51(10):778-85. PubMed ID: 11881730
[TBL] [Abstract][Full Text] [Related]
35. LMP1 promotes nasal NK/T-cell lymphoma cell function by eIF4E via NF-κB pathway.
Sun L; Zhao Y; Shi H; Ma C; Wei L
Oncol Rep; 2015 Dec; 34(6):3264-71. PubMed ID: 26397141
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
[TBL] [Abstract][Full Text] [Related]
37. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
38. EBV-associated lymphoproliferative disorders: classification and treatment.
Carbone A; Gloghini A; Dotti G
Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
[TBL] [Abstract][Full Text] [Related]
39. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
40. EBV in T-/NK-Cell Tumorigenesis.
Kimura H
Adv Exp Med Biol; 2018; 1045():459-475. PubMed ID: 29896680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
